✦ LIBER ✦

Risk-reducing surgery for breast and ovarian cancer risks - where are we now?

✍ Scribed by N Hallowell; B Baylock; L Heiniger; M Price; P Butow

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bisphosphonates and oesophageal cancer r

✍ Serge Rozenberg; Susan Dutton 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Adjuvant treatment for high risk melanom

✍ Anand Sharma; Tahir Abbas; Sarah Gwynne 📂 Article 📅 2008 🏛 PAGEPress Publications 🌐 English ⚖ 81 KB

Alcohol and breast cancer. Where are we

✍ Arthur Schafzkin; Matthew P. Longnecker 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 1023 KB

Cholesteryl ester transfer protein inhib

✍ Philip Barter; Kerry-Anne Rye 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 213 KB

Inflammatory bowel disease therapies and

✍ Beaugerie, L. 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 197 KB

Cancer: Where we are now and goals for 2

✍ Gerald L. Woolam 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views